SecBot SecBot
SECBOTREPLAY Home › Report › VRTX

VRTX · Two Vertex Pharmaceuticals EVPs, the Chief Commercial Officer and Chief…

VERTEX PHARMACEUTICALS INC / MA · CLUSTER filed Feb 24, 2026 at 19:00 ET

At the news

NEUTRALIMPACT 4/10

CLUSTER filed Feb 24, 2026 at 19:00 ET

Two Vertex Pharmaceuticals EVPs, the Chief Commercial Officer and Chief Legal Officer, sold shares in open-market transactions totaling approximately $1.6 million over the past week. These were opportunistic sales of existing holdings, not tied to a specific corporate event.

  • EVP and Chief Commercial Officer Duncan McKechnie sold 2,437 shares for $1,158,306.10 at $475.30 per share on March 4, 2026.
  • EVP and Chief Legal Officer Joy Liu sold 892 shares for $442,396.32 at $495.96 per share on March 2, 2026.
  • Total value of the insider trading cluster: $1,600,702.42 in open-market sales.
  • Both transactions were reported on Form 4 as open-market sales (code 'S'), indicating deliberate dispositions.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access